Cargando…
Barriers and Facilitators to Conducting Oncology Clinical Trials in the UAE
Cancer research and clinical trials are essential to improve cancer patients’ outcomes and advance the oncology field. The United Arab Emirates (UAE) has been lagging in cancer research with many barriers, including healthcare, institutional, regulatory, patient and community, the global oncology co...
Autor principal: | Al-Shamsi, Humaid O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680222/ https://www.ncbi.nlm.nih.gov/pubmed/36412672 http://dx.doi.org/10.3390/clinpract12060093 |
Ejemplares similares
-
A Proposal for a National Cancer Control Plan for the UAE: 2022–2026
por: Al-Shamsi, Humaid O., et al.
Publicado: (2022) -
Arab Countries and Oncology Clinical Trials: A Bibliometric Analysis
por: Al-Shamsi, Humaid O., et al.
Publicado: (2023) -
A potential rise of breast cancer risk in the UAE post-COVID-19 lockdown: A call for action
por: Ennab, Farah, et al.
Publicado: (2022) -
The State of Cancer Care in the United Arab Emirates in 2022
por: Al-Shamsi, Humaid O.
Publicado: (2022) -
Facilitators and barriers to conducting an efficient, competent and high-quality oncological multidisciplinary team meeting
por: Walraven, Janneke E W, et al.
Publicado: (2023)